PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 176 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $22,394,000 | -60.2% | 488,418 | -48.6% | 0.02% | -61.8% |
| Q2 2018 | $56,252,000 | +70.2% | 950,998 | +95.9% | 0.06% | +66.7% |
| Q1 2018 | $33,041,000 | +133.3% | 485,545 | +126.3% | 0.03% | +153.8% |
| Q2 2014 | $14,160,000 | -68.3% | 214,547 | -50.1% | 0.01% | -69.8% |
| Q1 2014 | $44,739,000 | +5.5% | 429,608 | +4.9% | 0.04% | +2.4% |
| Q4 2013 | $42,413,000 | +8.1% | 409,665 | -44.0% | 0.04% | +2.4% |
| Q3 2013 | $39,253,000 | -3.3% | 731,511 | -20.1% | 0.04% | -10.9% |
| Q2 2013 | $40,603,000 | – | 915,096 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |